STOCK TITAN

Corvex posts $17.5M net loss in Q3 2026 earnings

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Corvex, Inc. reported third-quarter 2026 revenue of $4.982 million and a net loss of $17.519 million; adjusted EBITDA, a non-GAAP measure, was a loss of $3.242 million. This was the company’s first full reporting period after the June 30, 2026 transfer of its legacy healthcare assets; prior-year periods reflect only that business and are not directly comparable.

Corvex said it secured all of the approximately 8 MW of critical IT capacity in its August plan. 1.5 MW is live and supports approximately $22 million of contracted ARR. The remaining capacity at the Mid-Atlantic 1 expansion and Midwest-1 is on track to be ready for service in the fourth quarter of 2026. The company is working to complete offtake for a planned 1.6 MW NVIDIA Blackwell cluster at Mid-Atlantic 1 and for 4.5 MW at Midwest-1, where it holds a right of first refusal on a further 12.5 MW in 2027.

As of November 10, 2026, approximately 39.1 million common shares were outstanding. Approximately 21,800 Series D Preferred shares were convertible into approximately 21.8 million common shares, or approximately 60.9 million common shares on an as-converted basis.

Filing Explained

The filing adds a dated liquidity snapshot: at September 30, 2026, Corvex reported $41,986 thousand in cash and cash equivalents, and $29,343 thousand in total liabilities; it used $16,567 thousand in operating cash over the first nine months of 2026.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Revenue $4.982 million Three months ended September 30, 2026
Net loss $17.519 million loss Three months ended September 30, 2026
Adjusted EBITDA $3.242 million loss Three months ended September 30, 2026; non-GAAP measure
Cash and cash equivalents $41.986 million As of September 30, 2026
Net cash used in operating activities $16.567 million Nine months ended September 30, 2026
contracted ARR financial
"supports approximately $22 million of contracted ARR"
right of first refusal financial
"hold a right of first refusal on a further 12.5 MW in 2027"
A right of first refusal gives an existing shareholder or party the chance to buy an asset or shares before the owner can sell them to someone else. Think of it like being offered the first option to buy a house when the owner decides to sell; it matters to investors because it can limit who can acquire a stake, slow or block transactions, and affect the price and liquidity of an investment by restricting open-market sales or new buyers.
Adjusted EBITDA financial
"Reconciliation of Net Loss to Adjusted EBITDA"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
as-converted basis financial
"approximately 60.9 million common shares on an as-converted basis"
As-converted basis means counting securities that can become common stock—like convertible bonds or preferred shares—as if they already were common shares when calculating totals such as shares outstanding, ownership percentages, or per-share metrics. Investors use it to see the potential dilution and the “what-if” size of the shareholder base; it’s like imagining all restaurant coupons have been redeemed so you know how crowded the table could become and how slices of the pie would shrink.
take-or-pay terms financial
"duration, pricing or take-or-pay terms we anticipate"
Revenue $4.982 million Prior-year periods are not directly comparable.
Loss from operations $17.437 million loss Prior-year periods are not directly comparable.
Net loss $17.519 million loss Prior-year periods are not directly comparable.
Adjusted EBITDA $3.242 million loss Prior-year periods are not directly comparable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What revenue did MOVE report for the third quarter of 2026?

Corvex reported $4.982 million in revenue for the three months ended September 30, 2026. The company said prior-year periods reflect only its legacy healthcare business and are not directly comparable.

What were MOVE’s net loss and adjusted EBITDA for the third quarter of 2026?

Corvex reported a $17.519 million net loss and a $3.242 million adjusted EBITDA loss for the third quarter of 2026. Adjusted EBITDA is a non-GAAP financial measure.

How much AI computing capacity has Corvex secured?

Corvex said it secured all of the approximately 8 MW of critical IT capacity in its August plan. Of that, 1.5 MW is live and supports approximately $22 million of contracted ARR; remaining capacity is on track to be ready for service in the fourth quarter of 2026.

How many MOVE common shares were outstanding as of November 10, 2026?

Corvex reported approximately 39.1 million common shares outstanding as of November 10, 2026. It also reported approximately 21,800 Series D Preferred shares convertible into approximately 21.8 million common shares, or approximately 60.9 million common shares on an as-converted basis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001734750 0001734750 2026-11-12 2026-11-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2026

 

CORVEX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40254   82-4233771
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

3401 North Fairfax Drive, Suite 3230,
Arlington, Virginia
  22226
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (866) GET-GPUS ((866) 438-4787)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   MOVE   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02 Results of Operations and Financial Condition.

 

On November 12, 2026, Corvex, Inc. announced its financial results for the quarter ended September 30, 2026. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01 - Financial Statements and Exhibits.

   

(d) Exhibits

 

Exhibit
Number
  Description
99.1   Press Release, dated November 12, 2026
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CORVEX, INC.
     
Date: November 12, 2026 By: /s/ Chance Moreland
    Chance Moreland
    Chief Financial Officer

 

2

 

Exhibit 99.1

 

Corvex Reports Third Quarter 2026 Results

 

ARLINGTON, Va., Nov. 12, 2026 /PRNewswire/ -- Corvex, Inc. (Nasdaq: MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today reported financial results for the third quarter ended September 30, 2026. The third quarter is the Company’s first full reporting period following the June 30, 2026 transfer of the legacy healthcare assets. Prior-year periods reflect only the legacy healthcare business and are therefore not directly comparable.

 

"We are building the Corvex AI Factory business one underwritten project at a time, and the third quarter moved that business forward. We have now secured all of the approximately 8 MW of critical IT capacity in the plan we set out in August. Of that capacity, 1.5 MW is live and supports approximately $22 million of contracted ARR. The remaining capacity, at the Mid-Atlantic 1 expansion and Midwest-1, is on track to be ready for service in the fourth quarter of 2026. We see customer demand that meets our underwriting criteria, and we are working to complete offtake for a 1.6 MW NVIDIA Blackwell cluster planned for Mid-Atlantic 1 and for 4.5 MW at Midwest-1, where we also hold a right of first refusal on a further 12.5 MW in 2027. We finance each deployment alongside our customers and lenders to clear its cost of capital, and we continue to advance new data center opportunities in our pipeline," said Jay Crystal, Co-Founder and Co-Chief Executive Officer of Corvex.

 

“Corvex is an engineering company first. In the third quarter we launched Corvex Token Factory on schedule and received notices of allowance for two patents covering Corvex’s technology, bringing our portfolio to two allowed patents and 10 pending patent applications. The goal is to get more useful work out of every GPU and every watt, on infrastructure customers can trust with their most sensitive data,” said Seth Demsey, Co-Founder and Co-Chief Executive Officer of Corvex.

 

Third Quarter 2026 Financial Highlights:

 

●Total revenue for the third quarter was $5.0 million, up 31% from $3.8 million in the second quarter of 2026. Revenue for the nine months ended September 30, 2026 was $9.3 million.

 

●Deferred revenue, including current and non-current portions, was $3.2 million at September 30, 2026, compared with $12,000 at December 31, 2025, reflecting amounts collected in advance for contracted AI compute capacity not yet recognized as revenue.

 

●Net loss attributable to common stockholders for the third quarter was $(17.5) million, or $(0.60) per share. Net loss attributable to common stockholders for the nine months ended September 30, 2026 was $(35.4) million, or $(3.22) per share.

 

●Adjusted EBITDA, a non-GAAP financial measure, was $(3.2) million for the third quarter and $(8.0) million for the nine months ended September 30, 2026. Adjusted EBITDA for AI Platform and services was $(3.2) million for the third quarter and $(5.6) million for the nine-month period.

 

●Total stock-based compensation expense was $11.3 million in the third quarter, including $9.3 million recorded in general and administrative expense.

 

●Cash and cash equivalents were $42.0 million at September 30, 2026. Cash used in operating activities for the three months ended September 30, 2026 was $7.0 million.

 

 

 

Business Highlights:

 

●Contracted annualized revenue on live compute was approximately $21.7 million as of November 12, 2026. Corvex defines this operating metric as the annualized value of fixed contractual fees on capacity that has been delivered, accepted by the customer and is generating revenue as of the stated date. It excludes contracted capacity that is not yet live, is not a forecast, and is not a GAAP financial measure.

 

●All AI Platform and services revenue today is generated under take-or-pay contracts rather than spot pricing, meaning that customers reserve compute and storage capacity under those agreements and pay the contracted fee regardless of utilization.

 

●Corvex launched Corvex Token Factory publicly on September 30, 2026, moving the serverless inference platform out of closed alpha as planned. Developers and enterprises can register at no cost, obtain an API key, and run open-weight models with zero data retention by default.

 

●On August 31, 2026, Corvex announced plans to grow critical IT capacity from approximately 1.5 MW to approximately 8 MW by the end of 2026, doubling capacity at its Mid-Atlantic 1 data center and establishing operations at its Midwest-1 facility. Corvex expects the Mid-Atlantic 1 expansion and Midwest-1 to be ready for service in the fourth quarter of 2026. Corvex also holds a right of first refusal on an additional 12.5 MW at Midwest-1, which could bring Corvex’s total capacity above 20 MW.

 

●In early September 2026, Corvex closed a private placement of approximately 4.26 million shares of common stock at $7.75 per share, for gross proceeds of approximately $33 million.

 

●In August 2026, a Corvex subsidiary entered into a secured equipment financing facility with USD.AI and borrowed $7.5 million to fund GPU servers for the Blackwell expansion at Mid-Atlantic 1. The loan is secured by the subsidiary’s assets, including the related customer contract, is supported by a limited guaranty from Corvex’s operating subsidiary, and is non-recourse to Corvex, Inc.

 

●In August 2026, Corvex appointed Garrett Brams, formerly a managing director at Cushman & Wakefield, to lead data center sourcing and development for its AI Factory platform. Corvex also appointed Michael Craig as Vice President of Architecture and Site Operations in July. Craig, a former Crusoe leader, brings more than 25 years of experience across HPC architecture, GPU infrastructure and operations.

 

Capital Structure Update

 

As of November 10, 2026, the Company had approximately 39.1 million shares of Common Stock outstanding and approximately 21,800 shares of Series D Preferred Stock outstanding, convertible into approximately 21.8 million shares of Common Stock, or approximately 60.9 million common shares on an as-converted basis.

 

2

 

Third Quarter 2026 Financial Highlights

(in thousands, except share and per share data) (unaudited)

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2026   2025   2026   2025 
Revenue  $4,982   $80   $9,294   $389 
Operating expenses   22,419    2,671    46,794    11,478 
Loss from operations   (17,437)   (2,591)   (37,500)   (11,089)
Other (expense) income, net   (82)   (1,438)   2,211    (1,343)
Loss before income tax expense   (17,519)   (4,029)   (35,289)   (12,432)
Income tax expense   —    —    —    — 
Net loss  $(17,519)  $(4,029)  $(35,289)  $(12,432)
                     
Cumulative dividends on Series A preferred stock   —    —    (155)   — 
Net loss attributable to common stockholders  $(17,519)  $(4,029)  $(35,444)  $(12,432)
                     
Net loss per share, basic and diluted  $(0.60)  $(3.49)  $(3.22)  $(11.71)
                     
Weighted average shares used in computing net loss per share, basic and diluted   29,006,953    1,155,780    11,002,465    1,061,224 

 

Reconciliation of Net Loss to Adjusted EBITDA

(in thousands) (unaudited)

 

   Three Months Ended
 September 30,
   Nine Months Ended
 September 30,
 
   2026   2025   2026   2025 
                 
Net loss  $(17,519)  $(4,029)  $(35,289)  $(12,432)
Depreciation and amortization   2,908    —    5,911    — 
Stock-based compensation(1)   11,287    691    22,853    1,770 
Transaction costs(2)   —    —    719    — 
Gain on disposal of business   (13)   —    (2,514)   — 
Interest and other income, net   95    1,438    303    1,343 
Adjusted EBITDA  $(3,242)  $(1,900)  $(8,017)  $(9,319)

 

(1)Stock-based compensation: related to incentive plans and inducement awards and the Company’s replacement awards related to the Merger.
(2)Related to the transaction costs associated with the Merger.

 

Investor Conference Call

 

Management will host a conference call and live audio webcast to discuss these results and provide a business update today at 8:30 a.m. ET / 5:30 a.m. PT. The live webcast of the earnings conference call can be accessed at the Corvex Investor Relations website at investors.corvex.ai. A replay of the webcast will be available at the same website. Investors and analysts with questions may contact Corvex Investor Relations at investor-relations@corvex.ai.

 

3

 

About Corvex

 

Corvex is an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads. Corvex’s platform allows organizations to leverage the advantage of AI by providing secure, scalable, and cost-efficient computational resources. Corvex’s infrastructure leverages advanced GPU-accelerated compute clusters, high-throughput storage systems and layered architecture to provide enhanced security, consistent performance, and efficiency at scale. As previously announced on March 19, 2026, Corvex, Inc. (formerly known as Movano Inc.) acquired Corvex Legacy Holdings, Inc. (Corvex OpCo, formerly known as Corvex, Inc.) (such acquisition the “Merger”). Following the Merger, the Company was renamed Corvex, Inc., effective March 23, 2026.

 

Forward-Looking Statements

 

This press release contains “forward-looking statements” within the meaning of applicable securities laws. Such statements are based on our current expectations, forecasts and assumptions and involve risks and uncertainties. These statements include, but are not limited to, statements related to our business; our strategy; our capital structure; our future growth; our technology; financial projections; our projections for future active power; demand for our platform including with respect to customer offtake agreements and customer-readiness dates; our plans to scale our platform and accelerate AI innovation; and strategic opportunities. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “project,” “will,” “would,” “should,” “could,” “can,” “predict,” “potential,” “target,” “explore,” “continue,” “outlook,” “guidance,” or the negative of these terms, where applicable, and similar expressions intended to identify forward-looking statements.

 

Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include but are not limited to our limited operating history, our ability to execute our business strategies and manage our growth, our ability to maintain and grow our customer base, continued demand for AI infrastructure as well as changes in prevailing market pricing for GPU-as-a-Service capacity, delays in arranging financing, procuring or installing equipment, or making facilities ready for deployment, delays in the delivery, commissioning or acceptance of GPU capacity, our potential inability to enter into customer offtake agreements at all, or to achieve the duration, pricing or take-or-pay terms we anticipate, our ability to perform our obligations under customer agreements as well as customers’ ability to perform their payment and other obligations; contract termination, modification or other rights affecting the realization of anticipated revenue, any disruption in our strategic relationships or disruptions with our third-party providers, including our suppliers and data center partners, our ability to develop and maintain our corporate infrastructure and internal controls, our financial performance, capital requirements and ability to raise additional capital and the impact of global political and macroeconomic conditions, including the effects of global geopolitical conflicts, inflation, tariffs, interest rates, any instability in the global banking sector and foreign currency exchange rates. More information about factors that could affect our operating results is included under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our most recent filings with the SEC, including in our Annual Report on Form 10-K for the year ended December 31, 2025 and our subsequent Quarterly Reports on Form 10-Q, copies of which may be obtained by visiting our Investor Relations website at investors.corvex.ai or the SEC’s website at www.sec.gov. Forward-looking statements speak only as of the date the statements are made and are based on information available to us at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. We assume no obligation to update forward-looking statements to reflect events or circumstances after the date they were made, except as required by law.

 

4

 

Non-GAAP Financial Measures

 

To supplement our consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States (“GAAP”), we use adjusted EBITDA to help us evaluate our business. We use this non-GAAP financial measure to make strategic decisions, establish business plans and forecasts, identify trends affecting our business, and evaluate operating performance. We believe that this non-GAAP financial measure may be helpful to investors because it allows for greater transparency into what measures we use in operating our business and measuring our performance and enables comparison of financial trends and results between periods where items may vary independent of business performance. This non-GAAP financial measure is presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled non-GAAP measures used by other companies.

 

Adjusted EBITDA is defined as net loss, excluding (i) depreciation and amortization, (ii) stock-based compensation, (iii) benefit from income taxes, (iv) transaction costs related to the Merger, (v) gain on disposal of assets and (vi) interest and other income, net. A reconciliation is provided below to reconcile adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Corvex encourages investors to review the related GAAP financial measure and the reconciliation of the non-GAAP financial measure to their most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate Corvex’s business.

 

Media Contact

 

corvex.media@stillpointglobaladvisors.com

 

Investor Contact

 

investor-relations@corvex.ai

 

5

 

CORVEX, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data) (unaudited)

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2026   2025   2026   2025 
REVENUE:                
Revenue - AI Platform and services  $4,982   $—   $9,259   $— 
Revenue - Connected devices and services   —    80    35    389 
Total revenue   4,982    80    9,294    389 
                     
OPERATING EXPENSES:                    
Cost of revenue - AI Platform and services (exclusive of depreciation and amortization)⁽¹⁾   2,520    —    4,876    — 
Cost of revenue - Connected devices and services (exclusive of depreciation and amortization)⁽²⁾   —    280    275    1,284 
Depreciation and amortization   2,908    —    5,911    — 
Technology and infrastructure⁽³⁾   1,319    1,166    3,507    4,950 
Sales and marketing⁽⁴⁾   842    —    1,883    — 
General and administrative⁽⁵⁾   14,830    1,225    30,342    5,244 
Total operating expenses   22,419    2,671    46,794    11,478 
                     
Loss from operations   (17,437)   (2,591)   (37,500)   (11,089)
                     
Other (expense) income, net:                    
Interest expense (related party)   —    (1,503)   (208)   (1,503)
Interest expense   (281)   —    (429)   — 
Other income, net   186    65    334    160 
Gain on disposal of business   13    —    2,514    — 
Other (expense) income, net   (82)   (1,438)   2,211    (1,343)
                     
Loss before income tax expense   (17,519)   (4,029)   (35,289)   (12,432)
Income tax expense   —    —    —    — 
Net loss  $(17,519)  $(4,029)  $(35,289)  $(12,432)
                     
Cumulative dividends on Series A preferred stock   —    —    (155)   — 
Net loss attributable to common stockholders  $(17,519)  $(4,029)  $(35,444)  $(12,432)
                     
Net loss per share, basic and diluted  $(0.60)  $(3.49)  $(3.22)  $(11.71)
                     
Weighted average shares used in computing net loss per share, basic and diluted   29,006,953    1,155,780    11,002,465    1,061,224 
                     
Amounts include stock-based compensation expense, as follows:                    
⁽¹⁾Cost of revenue - AI Platform and services (exclusive of depreciation and amortization)  $780   $—   $1,575   $— 
⁽²⁾Cost of revenue - Connected devices and services (exclusive of depreciation and amortization)   —    4    1    5 
⁽³⁾Technology and infrastructure   936    347    2,199    728 
⁽⁴⁾Sales and marketing   306    —    648    — 
⁽⁵⁾General and administrative   9,265    340    18,430    1,037 

 

6

 

CORVEX, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data) (unaudited)

 

   September 30,
2026
   December 31,
2025
 
ASSETS        
Current assets:        
Cash and cash equivalents  $41,986   $2,827 
Restricted cash   729    — 
Accounts receivable, net   1,673    — 
Inventory   —    1,766 
Prepaid expenses and other current assets   5,520    394 
Total current assets   49,908    4,987 
Property and equipment, net   39,095    101 
Operating lease right-of-use assets, net   4,672    415 
Intangible assets, net   14,731    — 
Goodwill   519,249    — 
Other assets   37    97 
Total assets  $627,692   $5,600 
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Current liabilities:          
Accounts payable  $3,864   $3,477 
Accrued liabilities   1,948    665 
Deferred revenue, current   1,892    12 
Bridge loan (related party)   —    4,382 
Operating lease liabilities, current   2,628    253 
Finance lease liabilities, current   3,964    18 
Loan payable, current   1,870    — 
Total current liabilities   16,166    8,807 
Operating lease liabilities, non-current   2,228    267 
Finance lease liabilities, non-current   4,549    — 
Deferred revenue, non-current   1,341    — 
Loan payable, non-current   5,059    — 
Total noncurrent liabilities   13,177    267 
Total liabilities   29,343    9,074 
Commitments and contingencies          
Stockholders’ equity (deficit):          
Preferred stock, $0.0001 par value, 5,000,000 shares authorized at September 30, 2026 and December 31, 2025; 21,791.0514 and 3,000 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively   232,117    2,850 
Common stock, $0.0001 par value, 500,000,000 shares authorized at September 30, 2026 and December 31, 2025; 39,076,693 and 1,228,272 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively   4    10 
Additional paid-in capital   567,909    160,058 
Accumulated deficit   (201,681)   (166,392)
Total stockholders’ equity (deficit)   598,349    (3,474)
Total liabilities and stockholders’ equity (deficit)  $627,692   $5,600 

 

7

 

CORVEX, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands) (unaudited)

 

   Nine Months Ended
September 30,
 
   2026   2025 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(35,289)  $(12,432)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   5,911    112 
Stock-based compensation   22,853    1,770 
Amortization of debt discount (related party)   118    1,465 
Amortization of debt issuance costs   38    — 
Interest expense on bridge loan (related party)   —    38 
Noncash lease expense   1,249    11 
Gain on disposal of business   (2,514)   — 
Changes in operating assets and liabilities, net of acquisition:          
Accounts receivable   (262)   — 
Inventory   (42)   (427)
Prepaid expenses and other current assets   (4,530)   52 
Other assets   60    (13)
Accounts payable   (1,141)   846 
Deferred revenue   (1,119)   (28)
Other current and noncurrent liabilities   —    (402)
Operating lease liabilities, net   (1,228)   — 
Accrued liabilities   (671)   — 
Net cash used in operating activities   (16,567)   (9,008)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (16,019)   — 
Capitalized internal use software   (643)   — 
Cash acquired in business combination   36,678    — 
Net cash provided by investing activities   20,016    — 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Payments on finance lease liabilities   (1,892)   — 
Proceeds from loans payable, net of lender fees   7,350    — 
Payment of debt issuance costs   (279)   — 
Repayments of loans payable   (180)   — 
Proceeds from bridge loan (related party)   —    1,500 
Issuance of common stock and Series D preferred stock in the Private Placement, net of issuance costs   30,976    — 
Issuance of common stock, net of issuance costs   —    1,606 
Issuance of common stock upon exercise of stock options   464    — 
Net cash provided by financing activities   36,439    3,106 
           
Net increase (decrease) in cash, cash equivalents and restricted cash   39,888    (5,902)
Cash, cash equivalents and restricted cash at beginning of period   2,827    7,902 
Cash, cash equivalents and restricted cash at end of period  $42,715   $2,000 
           
RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH:          
Cash and cash equivalents   41,986    2,000 
Restricted cash   729    — 
Total cash, cash equivalents and restricted cash  $42,715   $2,000 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid for interest  $387   $2 
Cash paid for income taxes  $1   $— 
NONCASH INVESTING AND FINANCING ACTIVITIES:          
Transaction expense adjustments  $207   $— 
Business acquired by issuance of equity instruments  $581,955   $— 
Bridge Loan (Related Party) extinguishment (Note 9)  $4,663   $— 
ROU assets obtained in exchange for operating lease liabilities  $2,029   $— 
Common shares issued from conversion of Series B Preferred shares  $2,576   $— 
Common shares issued from conversion of Series A, C and D Preferred shares  $347,939   $— 
Par value adjustment for stock splits and stock dividend  $10   $— 
Property and equipment in accounts payable and accrued liabilities  $647   $— 
Stock based compensation capitalized into internal use software  $610   $— 
Original issue discount on bridge loan (related party)  $—   $3,000 
Issuance costs on bridge loan (related party) recorded in accounts payable  $—   $10 
Accrued interest on bridge loan (related party) in other current liabilities  $—   $28 
Amortization of original issue discount on bridge loan (related party)  $—   $1,465 

 

8

 

Reconciliation of GAAP to Non-GAAP Results

Reconciliation of Net Loss to Adjusted EBITDA

(in thousands, except percentages)

 

   Three Months Ended
September 30,
   Change 
   2026   2025   $   % 
Net loss                
AI Platform and services  $(17,519)  $—   $(17,519)   NM 
Connected devices and services   —    (4,029)   4,029    100%
Total net loss  $(17,519)  $(4,029)  $(13,490)   (335)%
Adjusted EBITDA⁽¹⁾                    
AI Platform and services  $(3,242)  $—   $(3,242)   NM 
Connected devices and services   —    (1,900)   1,900    100%
Total adjusted EBITDA  $(3,242)  $(1,900)  $(1,342)   (71)%

 

   Nine Months Ended
September 30,
   Change 
   2026   2025   $   % 
Net loss                
AI Platform and services  $(33,061)  $—   $(33,061)   NM 
Connected devices and services   (2,228)   (12,432)   10,204    82%
Total net loss  $(35,289)  $(12,432)  $(22,857)   (184)%
Adjusted EBITDA⁽¹⁾                    
AI Platform and services  $(5,615)  $—   $(5,615)   NM 
Connected devices and services   (2,402)   (9,319)   6,917    74%
Total adjusted EBITDA  $(8,017)  $(9,319)  $1,302    14%

 

(1)See the “Non-GAAP Financial Measures” section included above for a reconciliation to the most directly comparable GAAP measure.

 

9

 

   Three Months Ended
September 30,
 
AI Platform and services  2026   2025 
Net loss  $(17,519)  $— 
Depreciation and amortization   2,908    — 
Stock-based compensation⁽¹⁾   11,287    — 
Gain on disposal of business   (13)   — 
Interest and other income, net   95    — 
Adjusted EBITDA  $(3,242)  $— 

 

   Nine Months Ended
September 30,
 
AI Platform and services  2026   2025 
Net loss  $(33,061)  $— 
Depreciation and amortization   5,792    — 
Stock-based compensation⁽¹⁾   21,565    — 
Gain on disposal of business   (13)   — 
Interest and other income, net   102    — 
Adjusted EBITDA  $(5,615)  $— 

 

   Three Months Ended
September 30,
 
Connected devices and services  2026   2025 
Net loss  $—   $(4,029)
Depreciation and amortization   —    — 
Stock-based compensation⁽¹⁾   —    691 
Gain on disposal of business   —    — 
Interest and other income, net   —    1,438 
Adjusted EBITDA  $—   $(1,900)

 

   Nine Months Ended
September 30,
Connected devices and services  2026  2025
Net loss  $(2,228)  $(12,432)
Depreciation and amortization   119    — 
Stock-based compensation⁽¹⁾   1,288    1,770 
Transaction costs⁽²⁾   719    — 
Gain on disposal of business   (2,501)   — 
Interest and other income, net   201    1,343 
Adjusted EBITDA  $(2,402)  $(9,319)

 

(1)Stock-based compensation: related to the 2019 and 2024 Incentive Plans for employees, contractors, or other entities.
(2)Related to the transaction costs associated with the Merger.

 

10

 

Filing Exhibits & Attachments

4 documents

Keep reading